Filing identity and reporting period
Important issuer mismatch: The supplied filing is Stable Road Acquisition Corp.’s Form 10-K, not a Momentus Inc. filing. It covers the fiscal year ended December 31, 2019; financial results are for the period from incorporation on May 28, 2019 through year-end, not a standalone 2019 fourth quarter. Stable Road was a newly formed blank-check company seeking a business combination, with a stated focus on cannabis-adjacent businesses. It had not begun operating activities.
Financial results and position
- Revenue: None. The company expected no operating revenue before a business combination.
- Net income: $62,359, comprising $346,011 of trust-account interest, offset by $236,085 of general and administrative expenses and $47,567 of income tax expense. The filing reports a $0.01 basic and diluted income per share for redeemable Class A shares and a $0.03 loss per share for non-redeemable shares.
- Cash flow: $356,959 used in operating activities. Financing activities provided $173,950,143; investing activities used $172,500,000, principally for the trust deposit.
- Liquidity and assets: At December 31, 2019, cash outside the trust was $1,093,184; cash and marketable securities in the trust were $172,846,011; total assets were $174,207,811. The filing also describes approximately $165.9 million as available for a business combination after deferred underwriting fees, before transaction costs.
- Liabilities and capital: Total liabilities were $7,095,309, including $6.9 million in deferred underwriting fees. There was no long-term debt. Class A shares subject to possible redemption were presented as temporary equity at $162,112,500; reported stockholders’ equity was $5,000,002.
- Margins: Not meaningful because the company had no revenue or operating business.
Material changes versus the prior comparable period
No prior-year comparable operating period is presented: the company was incorporated in May 2019 and completed its initial public offering in November 2019. The filing therefore does not provide a meaningful year-over-year operating trend.
Outlook, risks, and unusual items
- The company had until May 13, 2021 to complete a business combination or generally was required to redeem public shares and liquidate; warrants would expire worthless if no transaction closed.
- Management targeted cannabis-sector businesses that did not directly produce, distribute, or sell cannabis, and stated it would not pursue a target operating in violation of U.S. federal law. The proposed target enterprise value was generally above $300 million, so additional financing could be needed; none had been secured.
- Redemption requests, financing availability, competition for targets, management conflicts, dilution, and the limited time to complete a transaction could impair the company’s ability to close a deal. A qualifying transaction had to meet the stated 80% trust-asset fair-value test and provide control of the target.
- The filing identifies COVID-19 as a potential risk to deal sourcing and transaction execution; its specific impact was not determinable. Cannabis-related legal, regulatory, banking, market, and reputational uncertainties were also emphasized.
- Trust assets were invested in short-term U.S. Treasury securities or permitted money-market funds. Management reported no material market or interest-rate exposure at year-end.
- Disclosure controls were assessed as effective at December 31, 2019. The auditor issued an unqualified opinion on the financial statements; the auditor did not express an opinion on internal-control effectiveness.
Key facts investors should verify
- Confirm the issuer: this document is for Stable Road Acquisition Corp., not Momentus Inc.
- Review the audited statements and notes for the trust balance, redeemable-share classification, deferred underwriting fee, and reported per-share results.
- Check subsequent filings for whether Stable Road completed a business combination, amended its deadline, or liquidated, and for the eventual outcome for public shares and warrants.
- Verify any later disclosures about COVID-19, financing commitments, redemptions, and transaction-related dilution or conflicts of interest.